

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratan sulfate catabolic process (GO:0042340) | 5.60477406 |
| 2 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 5.30599179 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.97660684 |
| 4 | cell aggregation (GO:0098743) | 4.66038437 |
| 5 | cartilage condensation (GO:0001502) | 4.66038437 |
| 6 | hemidesmosome assembly (GO:0031581) | 4.55001549 |
| 7 | plasma membrane repair (GO:0001778) | 4.52369140 |
| 8 | muscle filament sliding (GO:0030049) | 4.46644895 |
| 9 | actin-myosin filament sliding (GO:0033275) | 4.46644895 |
| 10 | sarcomere organization (GO:0045214) | 4.39638189 |
| 11 | chondrocyte development (GO:0002063) | 4.38035630 |
| 12 | cardiac myofibril assembly (GO:0055003) | 4.32371339 |
| 13 | notochord development (GO:0030903) | 4.21761404 |
| 14 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.15012094 |
| 15 | actin-mediated cell contraction (GO:0070252) | 3.91118291 |
| 16 | myofibril assembly (GO:0030239) | 3.88295162 |
| 17 | cell adhesion mediated by integrin (GO:0033627) | 3.85312677 |
| 18 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84614032 |
| 19 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.79318629 |
| 20 | endothelial cell morphogenesis (GO:0001886) | 3.77452584 |
| 21 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.63435751 |
| 22 | desmosome organization (GO:0002934) | 3.60959874 |
| 23 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.60783876 |
| 24 | chondrocyte proliferation (GO:0035988) | 3.60491109 |
| 25 | collagen fibril organization (GO:0030199) | 3.58475136 |
| 26 | limb bud formation (GO:0060174) | 3.54705646 |
| 27 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.52613564 |
| 28 | atrioventricular valve morphogenesis (GO:0003181) | 3.43089732 |
| 29 | fibrinolysis (GO:0042730) | 3.38256903 |
| 30 | positive regulation of p38MAPK cascade (GO:1900745) | 3.37918607 |
| 31 | muscle tissue morphogenesis (GO:0060415) | 3.36082992 |
| 32 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.29516003 |
| 33 | positive regulation of extracellular matrix organization (GO:1903055) | 3.28378911 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 3.28285045 |
| 35 | cardiac muscle contraction (GO:0060048) | 3.28125233 |
| 36 | regulation of p38MAPK cascade (GO:1900744) | 3.25718618 |
| 37 | cardiac muscle cell development (GO:0055013) | 3.23895092 |
| 38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.20070925 |
| 39 | cellular response to vitamin D (GO:0071305) | 3.18466128 |
| 40 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.15140609 |
| 41 | cellular glucuronidation (GO:0052695) | 3.11297268 |
| 42 | cellular response to vitamin (GO:0071295) | 3.10840253 |
| 43 | endocardial cushion morphogenesis (GO:0003203) | 3.08936561 |
| 44 | regulation of cardioblast differentiation (GO:0051890) | 3.07907682 |
| 45 | cardiac cell development (GO:0055006) | 3.07092521 |
| 46 | sodium ion export (GO:0071436) | 3.06200667 |
| 47 | actin filament-based movement (GO:0030048) | 3.05856422 |
| 48 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05813549 |
| 49 | endochondral ossification (GO:0001958) | 3.05480990 |
| 50 | replacement ossification (GO:0036075) | 3.05480990 |
| 51 | heart trabecula formation (GO:0060347) | 2.98854886 |
| 52 | actomyosin structure organization (GO:0031032) | 2.97564028 |
| 53 | response to lead ion (GO:0010288) | 2.96607658 |
| 54 | cellular copper ion homeostasis (GO:0006878) | 2.94943847 |
| 55 | cellular response to zinc ion (GO:0071294) | 2.93999218 |
| 56 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.92707978 |
| 57 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.91385315 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 2.91104789 |
| 59 | virion attachment to host cell (GO:0019062) | 2.91104789 |
| 60 | striated muscle hypertrophy (GO:0014897) | 2.90380294 |
| 61 | cardiac muscle hypertrophy (GO:0003300) | 2.89464624 |
| 62 | cellular response to interferon-alpha (GO:0035457) | 2.88397272 |
| 63 | substrate-dependent cell migration (GO:0006929) | 2.87788229 |
| 64 | tooth mineralization (GO:0034505) | 2.84454334 |
| 65 | peptidyl-proline hydroxylation (GO:0019511) | 2.83985318 |
| 66 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.83114751 |
| 67 | heart valve morphogenesis (GO:0003179) | 2.82471143 |
| 68 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.81995942 |
| 69 | protein hydroxylation (GO:0018126) | 2.81889395 |
| 70 | uronic acid metabolic process (GO:0006063) | 2.81589117 |
| 71 | glucuronate metabolic process (GO:0019585) | 2.81589117 |
| 72 | striated muscle contraction (GO:0006941) | 2.80746230 |
| 73 | positive regulation of astrocyte differentiation (GO:0048711) | 2.80704016 |
| 74 | endodermal cell differentiation (GO:0035987) | 2.74507734 |
| 75 | response to vitamin D (GO:0033280) | 2.73427486 |
| 76 | apoptotic cell clearance (GO:0043277) | 2.72919474 |
| 77 | positive regulation of cartilage development (GO:0061036) | 2.72516367 |
| 78 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.69454965 |
| 79 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.69334319 |
| 80 | barbed-end actin filament capping (GO:0051016) | 2.68259075 |
| 81 | collagen metabolic process (GO:0032963) | 2.66348674 |
| 82 | collagen catabolic process (GO:0030574) | 2.66261491 |
| 83 | regulation of sarcomere organization (GO:0060297) | 2.65737306 |
| 84 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.64764344 |
| 85 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.64722341 |
| 86 | protein localization to endosome (GO:0036010) | 2.63469205 |
| 87 | cellular potassium ion homeostasis (GO:0030007) | 2.60836133 |
| 88 | proteoglycan metabolic process (GO:0006029) | 2.60731462 |
| 89 | tricarboxylic acid cycle (GO:0006099) | 2.59359366 |
| 90 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.57076222 |
| 91 | skin morphogenesis (GO:0043589) | 2.54891211 |
| 92 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.54541166 |
| 93 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.54379879 |
| 94 | carnitine shuttle (GO:0006853) | 2.53762972 |
| 95 | cartilage development (GO:0051216) | 2.53389706 |
| 96 | decidualization (GO:0046697) | 2.53156873 |
| 97 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.53007303 |
| 98 | cell communication involved in cardiac conduction (GO:0086065) | 2.52291803 |
| 99 | regulation of the force of heart contraction (GO:0002026) | 2.52177493 |
| 100 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.51928863 |
| 101 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.51849919 |
| 102 | negative regulation of coagulation (GO:0050819) | 2.50871915 |
| 103 | regulation of actin filament-based movement (GO:1903115) | 2.50843022 |
| 104 | muscle hypertrophy (GO:0014896) | 2.50496273 |
| 105 | adhesion of symbiont to host (GO:0044406) | 2.50248532 |
| 106 | lysine catabolic process (GO:0006554) | 2.49918259 |
| 107 | lysine metabolic process (GO:0006553) | 2.49918259 |
| 108 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.49151209 |
| 109 | 4-hydroxyproline metabolic process (GO:0019471) | 2.48605343 |
| 110 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.47801938 |
| 111 | negative regulation of wound healing (GO:0061045) | 2.47778431 |
| 112 | multicellular organismal catabolic process (GO:0044243) | 2.47355906 |
| 113 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.46848757 |
| 114 | negative regulation of potassium ion transport (GO:0043267) | 2.46833160 |
| 115 | extracellular matrix disassembly (GO:0022617) | 2.46286304 |
| 116 | mesenchyme morphogenesis (GO:0072132) | 2.46128938 |
| 117 | hypotonic response (GO:0006971) | 2.46122237 |
| 118 | keratan sulfate biosynthetic process (GO:0018146) | 2.45620085 |
| 119 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.45244673 |
| 120 | regulation of mononuclear cell migration (GO:0071675) | 2.44188727 |
| 121 | melanin biosynthetic process (GO:0042438) | 2.43948632 |
| 122 | glomerular basement membrane development (GO:0032836) | 2.43384929 |
| 123 | cellular response to cadmium ion (GO:0071276) | 2.42889570 |
| 124 | fatty acid transmembrane transport (GO:1902001) | 2.42861017 |
| 125 | negative regulation of heart growth (GO:0061117) | 2.41962701 |
| 126 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.41962701 |
| 127 | type B pancreatic cell proliferation (GO:0044342) | 2.41883283 |
| 128 | multicellular organismal metabolic process (GO:0044236) | 2.41538224 |
| 129 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.41357971 |
| 130 | negative regulation of lipase activity (GO:0060192) | 2.40673091 |
| 131 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.40661704 |
| 132 | iron ion import (GO:0097286) | 2.40321558 |
| 133 | negative regulation of protein localization to cell surface (GO:2000009) | 2.40265171 |
| 134 | response to gravity (GO:0009629) | 2.39838907 |
| 135 | ventricular cardiac muscle cell development (GO:0055015) | 2.39635843 |
| 136 | chondrocyte differentiation (GO:0002062) | 2.39026007 |
| 137 | regulation of plasminogen activation (GO:0010755) | 2.38456603 |
| 138 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.37924678 |
| 139 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37771611 |
| 140 | regulation of relaxation of muscle (GO:1901077) | 2.37637663 |
| 141 | kidney mesenchyme development (GO:0072074) | 2.36503827 |
| 142 | ER overload response (GO:0006983) | 2.36386017 |
| 143 | cell-substrate junction assembly (GO:0007044) | 2.36366574 |
| 144 | positive regulation of odontogenesis (GO:0042482) | 2.36176201 |
| 145 | regulation of vitamin metabolic process (GO:0030656) | 2.36033767 |
| 146 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.35675972 |
| 147 | response to BMP (GO:0071772) | 2.35446404 |
| 148 | cellular response to BMP stimulus (GO:0071773) | 2.35446404 |
| 149 | cell migration involved in heart development (GO:0060973) | 2.34910281 |
| 150 | amino-acid betaine transport (GO:0015838) | 2.34703940 |
| 151 | negative regulation of blood coagulation (GO:0030195) | 2.34475178 |
| 152 | negative regulation of hemostasis (GO:1900047) | 2.34475178 |
| 153 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.31974182 |
| 154 | extracellular matrix assembly (GO:0085029) | 2.31346283 |
| 155 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.30171542 |
| 156 | response to cadmium ion (GO:0046686) | 2.24167686 |
| 157 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.21966556 |
| 158 | positive regulation of calcium ion import (GO:0090280) | 2.21917005 |
| 159 | chondroitin sulfate catabolic process (GO:0030207) | 2.20724708 |
| 160 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.20656268 |
| 161 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.19469294 |
| 162 | metanephric mesenchyme development (GO:0072075) | 2.18824927 |
| 163 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.18070341 |
| 164 | positive regulation of positive chemotaxis (GO:0050927) | 2.17954859 |
| 165 | lymphangiogenesis (GO:0001946) | 2.16453753 |
| 166 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.15575827 |
| 167 | wound healing, spreading of epidermal cells (GO:0035313) | 2.15236308 |
| 168 | epithelial cell-cell adhesion (GO:0090136) | 2.14967436 |
| 169 | Rac protein signal transduction (GO:0016601) | 2.14955533 |
| 170 | negative regulation of complement activation (GO:0045916) | 2.13550646 |
| 171 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.11565301 |
| 172 | positive regulation of osteoblast proliferation (GO:0033690) | 2.11534464 |
| 173 | regulation of positive chemotaxis (GO:0050926) | 2.11491872 |
| 174 | endothelial cell chemotaxis (GO:0035767) | 2.10267625 |
| 175 | positive regulation of receptor recycling (GO:0001921) | 2.10265325 |
| 176 | response to parathyroid hormone (GO:0071107) | 2.10181341 |
| 177 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.08594137 |
| 178 | extracellular fibril organization (GO:0043206) | 2.08506323 |
| 179 | neural crest cell development (GO:0014032) | 2.08226209 |
| 180 | negative regulation of platelet activation (GO:0010544) | 2.07691659 |
| 181 | positive regulation of axon extension (GO:0045773) | 2.07388361 |
| 182 | glial cell migration (GO:0008347) | 2.07265790 |
| 183 | basement membrane organization (GO:0071711) | 2.06466522 |
| 184 | melanin metabolic process (GO:0006582) | 2.06313873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.00509221 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.21696063 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87755822 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52588159 |
| 5 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.51158180 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.31439657 |
| 7 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.29002993 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26344956 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16994149 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.04628433 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.04495385 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.96691660 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88769822 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.88376325 |
| 15 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.84420767 |
| 16 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.83251399 |
| 17 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77314906 |
| 18 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.74583402 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71123268 |
| 20 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.69682931 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.69682931 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64062308 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63827119 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60933286 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59465650 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58144082 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55770341 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51202327 |
| 29 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48907707 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48205675 |
| 31 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47265042 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45162963 |
| 33 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42995840 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42995840 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42943783 |
| 36 | TP53_16413492_ChIP-PET_HCT116_Human | 1.41719990 |
| 37 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39817490 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39686783 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39372288 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32437055 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32365423 |
| 42 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30862778 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.30736749 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29199473 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27750805 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.27179867 |
| 47 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26169320 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24472020 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23917573 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23785980 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23690706 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22858816 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22458367 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22333276 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21441449 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.20852834 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20368773 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19537007 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19401792 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19401792 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19394846 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19200514 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18428394 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16994822 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16842254 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16756166 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16631257 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16456333 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15591552 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15300449 |
| 71 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.14058586 |
| 72 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13760016 |
| 73 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12717033 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11320031 |
| 75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.11268602 |
| 76 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11113977 |
| 77 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11023474 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10010359 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10010359 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09680170 |
| 81 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09205542 |
| 82 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07380782 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07145059 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06486058 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04866748 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04695957 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04065455 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03744639 |
| 89 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03576121 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03044356 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03014298 |
| 92 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02460170 |
| 93 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02414177 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01723669 |
| 95 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00531149 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99588410 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99330279 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99187254 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99072079 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98416864 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97109182 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96548569 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96080015 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95609129 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95101317 |
| 106 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94966206 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93624823 |
| 108 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93271436 |
| 109 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93266574 |
| 110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93181506 |
| 111 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92678058 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92066390 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92032563 |
| 114 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91564431 |
| 115 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.91062603 |
| 116 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.90924988 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90808151 |
| 118 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90511560 |
| 119 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90501521 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90271201 |
| 121 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90121143 |
| 122 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88750143 |
| 123 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88737893 |
| 124 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88016337 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87843636 |
| 126 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87656378 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87384680 |
| 128 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87308776 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86809932 |
| 130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86481418 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85107885 |
| 132 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.85038209 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.84995440 |
| 134 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84054175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.41164429 |
| 2 | MP0000751_myopathy | 4.22055001 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.51106406 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.32537825 |
| 5 | MP0000749_muscle_degeneration | 3.04924031 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.98630603 |
| 7 | MP0005171_absent_coat_pigmentation | 2.95699232 |
| 8 | MP0002282_abnormal_trachea_morphology | 2.72220014 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.65290870 |
| 10 | MP0005275_abnormal_skin_tensile | 2.63224648 |
| 11 | MP0000678_abnormal_parathyroid_gland | 2.56621564 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.52380654 |
| 13 | MP0005503_abnormal_tendon_morphology | 2.49298794 |
| 14 | MP0005330_cardiomyopathy | 2.33807184 |
| 15 | MP0004272_abnormal_basement_membrane | 2.32785709 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.21331514 |
| 17 | MP0002933_joint_inflammation | 2.20370446 |
| 18 | MP0004134_abnormal_chest_morphology | 2.19349115 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.16274521 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.15768905 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.15595793 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.13307443 |
| 23 | MP0004087_abnormal_muscle_fiber | 2.09658604 |
| 24 | MP0005620_abnormal_muscle_contractility | 1.95474030 |
| 25 | MP0009250_abnormal_appendicular_skeleto | 1.90419756 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.88362643 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.84931541 |
| 28 | MP0005408_hypopigmentation | 1.84670321 |
| 29 | MP0000762_abnormal_tongue_morphology | 1.79601539 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.78915863 |
| 31 | MP0000163_abnormal_cartilage_morphology | 1.74179416 |
| 32 | MP0006054_spinal_hemorrhage | 1.73471521 |
| 33 | MP0009384_cardiac_valve_regurgitation | 1.72347498 |
| 34 | MP0000747_muscle_weakness | 1.69043496 |
| 35 | MP0006138_congestive_heart_failure | 1.68657739 |
| 36 | MP0002106_abnormal_muscle_physiology | 1.66382417 |
| 37 | MP0002896_abnormal_bone_mineralization | 1.62652999 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.60189853 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.60189853 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.52283358 |
| 41 | * MP0004484_altered_response_of | 1.51338047 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.49277741 |
| 43 | MP0001958_emphysema | 1.47441185 |
| 44 | MP0005369_muscle_phenotype | 1.47103827 |
| 45 | MP0003279_aneurysm | 1.46945291 |
| 46 | MP0005197_abnormal_uvea_morphology | 1.46689161 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.44992568 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.44955771 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.42827367 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.41101169 |
| 51 | MP0002115_abnormal_skeleton_extremities | 1.40000507 |
| 52 | MP0003137_abnormal_impulse_conducting | 1.39816655 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.38907994 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.38416587 |
| 55 | MP0008004_abnormal_stomach_pH | 1.38363485 |
| 56 | MP0002108_abnormal_muscle_morphology | 1.38190267 |
| 57 | MP0003329_amyloid_beta_deposits | 1.34340361 |
| 58 | MP0004085_abnormal_heartbeat | 1.34303227 |
| 59 | MP0002269_muscular_atrophy | 1.32355186 |
| 60 | MP0005508_abnormal_skeleton_morphology | 1.31747194 |
| 61 | MP0005409_darkened_coat_color | 1.30685521 |
| 62 | * MP0000343_altered_response_to | 1.29214126 |
| 63 | MP0004233_abnormal_muscle_weight | 1.29056976 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.28675703 |
| 65 | MP0003950_abnormal_plasma_membrane | 1.26340407 |
| 66 | MP0004130_abnormal_muscle_cell | 1.25458498 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.23049373 |
| 68 | MP0003828_pulmonary_edema | 1.18358651 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.17334268 |
| 70 | MP0002796_impaired_skin_barrier | 1.15208451 |
| 71 | MP0002168_other_aberrant_phenotype | 1.14801564 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.13069567 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.12898301 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 1.11697188 |
| 75 | MP0000372_irregular_coat_pigmentation | 1.11658301 |
| 76 | MP0005023_abnormal_wound_healing | 1.10898156 |
| 77 | MP0003941_abnormal_skin_development | 1.10894766 |
| 78 | MP0003385_abnormal_body_wall | 1.10383019 |
| 79 | MP0003868_abnormal_feces_composition | 1.10130898 |
| 80 | MP0000920_abnormal_myelination | 1.08520300 |
| 81 | MP0002113_abnormal_skeleton_development | 1.07168283 |
| 82 | MP0005360_urolithiasis | 1.06422970 |
| 83 | MP0002234_abnormal_pharynx_morphology | 1.05796771 |
| 84 | MP0000604_amyloidosis | 1.05425770 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.03387393 |
| 86 | MP0005390_skeleton_phenotype | 1.02005636 |
| 87 | MP0001915_intracranial_hemorrhage | 1.01763537 |
| 88 | MP0003303_peritoneal_inflammation | 1.01100631 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 1.00281881 |
| 90 | MP0002060_abnormal_skin_morphology | 0.99523738 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.98970625 |
| 92 | MP0000516_abnormal_urinary_system | 0.98970625 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.98801906 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.98740912 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.97277387 |
| 96 | * MP0005166_decreased_susceptibility_to | 0.94939445 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.94936025 |
| 98 | MP0004510_myositis | 0.89585131 |
| 99 | MP0002090_abnormal_vision | 0.87480548 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 0.87178409 |
| 101 | * MP0003448_altered_tumor_morphology | 0.86672639 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 0.86239663 |
| 103 | MP0003091_abnormal_cell_migration | 0.85344582 |
| 104 | MP0003195_calcinosis | 0.84840667 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.84669170 |
| 106 | MP0002254_reproductive_system_inflammat | 0.83461287 |
| 107 | MP0000371_diluted_coat_color | 0.83313388 |
| 108 | MP0001542_abnormal_bone_strength | 0.82601403 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.82268404 |
| 110 | MP0004043_abnormal_pH_regulation | 0.81756570 |
| 111 | MP0006082_CNS_inflammation | 0.81343766 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.81181478 |
| 113 | MP0000733_abnormal_muscle_development | 0.80229102 |
| 114 | MP0003136_yellow_coat_color | 0.80024816 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.79792053 |
| 116 | MP0003634_abnormal_glial_cell | 0.79137912 |
| 117 | MP0003755_abnormal_palate_morphology | 0.78797842 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.77553824 |
| 119 | MP0002109_abnormal_limb_morphology | 0.77037194 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.76423642 |
| 121 | MP0005164_abnormal_response_to | 0.75996266 |
| 122 | MP0003795_abnormal_bone_structure | 0.72855802 |
| 123 | MP0001324_abnormal_eye_pigmentation | 0.70926784 |
| 124 | MP0001243_abnormal_dermal_layer | 0.70618407 |
| 125 | MP0004858_abnormal_nervous_system | 0.70478635 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.70278884 |
| 127 | MP0001881_abnormal_mammary_gland | 0.69829962 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.69819965 |
| 129 | MP0009053_abnormal_anal_canal | 0.69667143 |
| 130 | MP0009840_abnormal_foam_cell | 0.69353993 |
| 131 | MP0002128_abnormal_blood_circulation | 0.69100359 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.68538608 |
| 133 | MP0003935_abnormal_craniofacial_develop | 0.68094729 |
| 134 | * MP0000266_abnormal_heart_morphology | 0.67994865 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.67707877 |
| 136 | MP0001853_heart_inflammation | 0.67454558 |
| 137 | MP0002133_abnormal_respiratory_system | 0.67304906 |
| 138 | MP0005388_respiratory_system_phenotype | 0.67304906 |
| 139 | MP0001270_distended_abdomen | 0.66887595 |
| 140 | MP0002938_white_spotting | 0.66514457 |
| 141 | MP0001501_abnormal_sleep_pattern | 0.66461945 |
| 142 | MP0005085_abnormal_gallbladder_physiolo | 0.66204926 |
| 143 | MP0005187_abnormal_penis_morphology | 0.64395975 |
| 144 | MP0005165_increased_susceptibility_to | 0.62623036 |
| 145 | MP0003045_fibrosis | 0.62228603 |
| 146 | MP0003075_altered_response_to | 0.61352628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 7.43510084 |
| 2 | Vitreoretinal degeneration (HP:0000655) | 6.53976205 |
| 3 | Irregular epiphyses (HP:0010582) | 6.53095619 |
| 4 | Hypoplastic ischia (HP:0003175) | 6.13209359 |
| 5 | Abnormality of the ischium (HP:0003174) | 5.47666452 |
| 6 | Cupped ribs (HP:0000887) | 5.11782870 |
| 7 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.88241479 |
| 8 | Abnormal tarsal ossification (HP:0008369) | 4.36049434 |
| 9 | Flat acetabular roof (HP:0003180) | 4.26516809 |
| 10 | Small epiphyses (HP:0010585) | 4.14892562 |
| 11 | Hyperphosphatemia (HP:0002905) | 3.79139800 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.76946634 |
| 13 | Flat capital femoral epiphysis (HP:0003370) | 3.76668491 |
| 14 | Delayed epiphyseal ossification (HP:0002663) | 3.74921710 |
| 15 | Follicular hyperkeratosis (HP:0007502) | 3.73376677 |
| 16 | Muscle fiber splitting (HP:0003555) | 3.73095718 |
| 17 | Vascular tortuosity (HP:0004948) | 3.65618008 |
| 18 | Arterial tortuosity (HP:0005116) | 3.64059012 |
| 19 | Metaphyseal cupping (HP:0003021) | 3.63803371 |
| 20 | Aortic dissection (HP:0002647) | 3.52176455 |
| 21 | Arthropathy (HP:0003040) | 3.51553497 |
| 22 | Tetany (HP:0001281) | 3.43406141 |
| 23 | Genu varum (HP:0002970) | 3.40394598 |
| 24 | Neonatal short-limb short stature (HP:0008921) | 3.31159623 |
| 25 | Mitral stenosis (HP:0001718) | 3.29549222 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.25056704 |
| 27 | Increased connective tissue (HP:0009025) | 3.19682235 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.19040817 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.16917366 |
| 30 | Flattened epiphyses (HP:0003071) | 3.14144082 |
| 31 | Exercise-induced muscle cramps (HP:0003710) | 3.14060912 |
| 32 | Osteoarthritis (HP:0002758) | 3.11324277 |
| 33 | Soft skin (HP:0000977) | 3.11027743 |
| 34 | Abnormal foot bone ossification (HP:0010675) | 3.05301564 |
| 35 | Sudden death (HP:0001699) | 3.03314514 |
| 36 | Hypoplasia of the iris (HP:0007676) | 2.99746349 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97565969 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97565969 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97565969 |
| 40 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.97396748 |
| 41 | Abnormality of femoral epiphyses (HP:0006499) | 2.97396748 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.91378574 |
| 43 | Abnormality of the vertebral endplates (HP:0005106) | 2.91139000 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.91043135 |
| 45 | Protuberant abdomen (HP:0001538) | 2.87002553 |
| 46 | Glomerulonephritis (HP:0000099) | 2.86904377 |
| 47 | Abnormal vertebral ossification (HP:0100569) | 2.85610362 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.84713022 |
| 49 | Abnormality of the calf musculature (HP:0001430) | 2.84645370 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.84364491 |
| 51 | Waddling gait (HP:0002515) | 2.82155048 |
| 52 | Abnormality of the pubic bones (HP:0003172) | 2.80076649 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.79980988 |
| 54 | Hip contracture (HP:0003273) | 2.79958525 |
| 55 | White forelock (HP:0002211) | 2.78356923 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.76656908 |
| 57 | Blue sclerae (HP:0000592) | 2.74094480 |
| 58 | Ventricular tachycardia (HP:0004756) | 2.71489536 |
| 59 | Patchy hypopigmentation of hair (HP:0011365) | 2.70993714 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.70044584 |
| 61 | Abnormality of dentin (HP:0010299) | 2.68637960 |
| 62 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.67493808 |
| 63 | Absent epiphyses (HP:0010577) | 2.67493808 |
| 64 | Mild short stature (HP:0003502) | 2.65900662 |
| 65 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.65327394 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.62778698 |
| 67 | Bladder diverticulum (HP:0000015) | 2.61944226 |
| 68 | Cervical subluxation (HP:0003308) | 2.61927867 |
| 69 | Limited hip movement (HP:0008800) | 2.61316289 |
| 70 | Coxa vara (HP:0002812) | 2.60806926 |
| 71 | Metaphyseal irregularity (HP:0003025) | 2.53750181 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.52910285 |
| 73 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.52696582 |
| 74 | Ankle contracture (HP:0006466) | 2.52658999 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.52032382 |
| 76 | Short femoral neck (HP:0100864) | 2.51369086 |
| 77 | Ovoid vertebral bodies (HP:0003300) | 2.51064501 |
| 78 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.47779099 |
| 79 | Wormian bones (HP:0002645) | 2.45363843 |
| 80 | Spondylolisthesis (HP:0003302) | 2.44236907 |
| 81 | Amelogenesis imperfecta (HP:0000705) | 2.43174770 |
| 82 | Irregular vertebral endplates (HP:0003301) | 2.42557632 |
| 83 | Calf muscle hypertrophy (HP:0008981) | 2.42341752 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 2.38427443 |
| 85 | Cholecystitis (HP:0001082) | 2.38427443 |
| 86 | Hyperextensible skin (HP:0000974) | 2.37867830 |
| 87 | Ulnar deviation of the wrist (HP:0003049) | 2.37498967 |
| 88 | Osteolytic defects of the hand bones (HP:0009699) | 2.37410042 |
| 89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37410042 |
| 90 | Abnormality of carpal bone ossification (HP:0006257) | 2.36915966 |
| 91 | Platyspondyly (HP:0000926) | 2.34898356 |
| 92 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.33053869 |
| 93 | Tetraparesis (HP:0002273) | 2.32815613 |
| 94 | Complement deficiency (HP:0004431) | 2.31489881 |
| 95 | EMG: myopathic abnormalities (HP:0003458) | 2.31268572 |
| 96 | Deep venous thrombosis (HP:0002625) | 2.29312855 |
| 97 | Genu recurvatum (HP:0002816) | 2.28788741 |
| 98 | Thin ribs (HP:0000883) | 2.26752507 |
| 99 | Dysostosis multiplex (HP:0000943) | 2.26246388 |
| 100 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.25521692 |
| 101 | Vertebral hypoplasia (HP:0008417) | 2.25521692 |
| 102 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.25385900 |
| 103 | Muscle fiber inclusion bodies (HP:0100299) | 2.24835727 |
| 104 | Vascular calcification (HP:0004934) | 2.23850633 |
| 105 | Atrial fibrillation (HP:0005110) | 2.22516877 |
| 106 | Broad metatarsal (HP:0001783) | 2.22363182 |
| 107 | Aortic aneurysm (HP:0004942) | 2.21562737 |
| 108 | Spinal rigidity (HP:0003306) | 2.20668125 |
| 109 | Exostoses (HP:0100777) | 2.20240401 |
| 110 | Renal duplication (HP:0000075) | 2.20210749 |
| 111 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.19062412 |
| 112 | Peritonitis (HP:0002586) | 2.18622936 |
| 113 | Abnormality of the femoral head (HP:0003368) | 2.17966593 |
| 114 | Difficulty climbing stairs (HP:0003551) | 2.17279736 |
| 115 | Patent foramen ovale (HP:0001655) | 2.16360796 |
| 116 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.16134270 |
| 117 | Axonal loss (HP:0003447) | 2.13494821 |
| 118 | Beaking of vertebral bodies (HP:0004568) | 2.09800639 |
| 119 | Metaphyseal dysplasia (HP:0100255) | 2.09361988 |
| 120 | Alacrima (HP:0000522) | 2.08343747 |
| 121 | Shallow orbits (HP:0000586) | 2.07386073 |
| 122 | Primary atrial arrhythmia (HP:0001692) | 2.05532096 |
| 123 | Abnormality of complement system (HP:0005339) | 2.04758437 |
| 124 | Limb-girdle muscle atrophy (HP:0003797) | 2.04629652 |
| 125 | Nephritis (HP:0000123) | 2.04298303 |
| 126 | Pulmonary artery stenosis (HP:0004415) | 2.03573144 |
| 127 | Lumbar hyperlordosis (HP:0002938) | 2.02850929 |
| 128 | Thin bony cortex (HP:0002753) | 2.01142684 |
| 129 | Scapular winging (HP:0003691) | 2.00245229 |
| 130 | Stillbirth (HP:0003826) | 2.00167913 |
| 131 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.00060957 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.99950872 |
| 133 | Premature rupture of membranes (HP:0001788) | 1.99055758 |
| 134 | Asymmetric septal hypertrophy (HP:0001670) | 1.98454816 |
| 135 | Vertebral clefting (HP:0008428) | 1.98005809 |
| 136 | Fragile skin (HP:0001030) | 1.97384989 |
| 137 | Thoracolumbar scoliosis (HP:0002944) | 1.96222887 |
| 138 | Abnormality of the vitreous humor (HP:0004327) | 1.95928824 |
| 139 | Venous insufficiency (HP:0005293) | 1.95875076 |
| 140 | Mucopolysacchariduria (HP:0008155) | 1.93014461 |
| 141 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93014461 |
| 142 | Decreased lacrimation (HP:0000633) | 1.92663619 |
| 143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.92407749 |
| 144 | Supraventricular arrhythmia (HP:0005115) | 1.91406056 |
| 145 | Supraventricular tachycardia (HP:0004755) | 1.91069238 |
| 146 | Dilatation of the ascending aorta (HP:0005111) | 1.90763569 |
| 147 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90368922 |
| 148 | Abnormality of the costochondral junction (HP:0000919) | 1.89600600 |
| 149 | Myoglobinuria (HP:0002913) | 1.89569738 |
| 150 | Myocardial infarction (HP:0001658) | 1.88854289 |
| 151 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88196340 |
| 152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88196340 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88196340 |
| 154 | Venous abnormality (HP:0002624) | 1.87197144 |
| 155 | Enlarged epiphyses (HP:0010580) | 1.86952515 |
| 156 | Myotonia (HP:0002486) | 1.86951419 |
| 157 | Abnormal hand bone ossification (HP:0010660) | 1.86611070 |
| 158 | Lipoatrophy (HP:0100578) | 1.85619492 |
| 159 | Long toe (HP:0010511) | 1.85597830 |
| 160 | Difficulty running (HP:0009046) | 1.83641395 |
| 161 | Overgrowth (HP:0001548) | 1.83495604 |
| 162 | Ulnar claw (HP:0001178) | 1.83020554 |
| 163 | Hypoplasia of the odontoid process (HP:0003311) | 1.82656549 |
| 164 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82631151 |
| 165 | Nemaline bodies (HP:0003798) | 1.82296188 |
| 166 | Congenital glaucoma (HP:0001087) | 1.82012828 |
| 167 | Severe Myopia (HP:0011003) | 1.81465756 |
| 168 | Short nail (HP:0001799) | 1.79415230 |
| 169 | Abnormal ossification of hand bones (HP:0005921) | 1.79286249 |
| 170 | Abnormality of incisor morphology (HP:0011063) | 1.79138032 |
| 171 | Ocular albinism (HP:0001107) | 1.78839624 |
| 172 | Action tremor (HP:0002345) | 1.78649354 |
| 173 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.78483382 |
| 174 | Blue irides (HP:0000635) | 1.78408255 |
| 175 | Atrophic scars (HP:0001075) | 1.78261410 |
| 176 | Joint stiffness (HP:0001387) | 1.77952584 |
| 177 | Distal upper limb amyotrophy (HP:0007149) | 1.77404184 |
| 178 | Upper limb amyotrophy (HP:0009129) | 1.77404184 |
| 179 | J-shaped sella turcica (HP:0002680) | 1.73591463 |
| 180 | Elbow flexion contracture (HP:0002987) | 1.71626936 |
| 181 | Tibial bowing (HP:0002982) | 1.70501720 |
| 182 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69467602 |
| 183 | Hypoventilation (HP:0002791) | 1.68793112 |
| 184 | Aortic regurgitation (HP:0001659) | 1.67761278 |
| 185 | Mitral valve prolapse (HP:0001634) | 1.65189795 |
| 186 | Slender build (HP:0001533) | 1.65164778 |
| 187 | Supranuclear gaze palsy (HP:0000605) | 1.64982588 |
| 188 | Nuclear cataract (HP:0100018) | 1.63602782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 5.78028145 |
| 2 | TRIM28 | 4.85875510 |
| 3 | OBSCN | 4.06603162 |
| 4 | STK38L | 3.55436437 |
| 5 | DDR2 | 3.48305810 |
| 6 | STK24 | 3.45879016 |
| 7 | NME1 | 3.09762806 |
| 8 | TTN | 2.90228107 |
| 9 | TRIB3 | 2.46010823 |
| 10 | PHKG1 | 2.23617939 |
| 11 | PHKG2 | 2.23617939 |
| 12 | LATS1 | 2.05079873 |
| 13 | LATS2 | 1.94091531 |
| 14 | TGFBR2 | 1.89443653 |
| 15 | PDK2 | 1.87151934 |
| 16 | PRKD3 | 1.79460172 |
| 17 | IRAK3 | 1.77888436 |
| 18 | EPHB2 | 1.76913719 |
| 19 | TIE1 | 1.75487167 |
| 20 | TAOK1 | 1.71815776 |
| 21 | DMPK | 1.68959803 |
| 22 | PRKG2 | 1.61670478 |
| 23 | MAP3K12 | 1.60670681 |
| 24 | RIPK1 | 1.58700477 |
| 25 | MAPK12 | 1.57113680 |
| 26 | WNK4 | 1.45370656 |
| 27 | ARAF | 1.41783585 |
| 28 | PKN2 | 1.37768351 |
| 29 | PDK3 | 1.32272724 |
| 30 | PDK4 | 1.32272724 |
| 31 | MYLK | 1.29704367 |
| 32 | * MAP3K3 | 1.28950908 |
| 33 | ABL2 | 1.27427961 |
| 34 | MAP3K11 | 1.19846313 |
| 35 | ROCK1 | 1.19390331 |
| 36 | EPHA3 | 1.15698770 |
| 37 | FER | 1.14738479 |
| 38 | PIK3CA | 1.13974093 |
| 39 | LMTK2 | 1.13637155 |
| 40 | PAK4 | 1.13361366 |
| 41 | EPHB1 | 1.13095327 |
| 42 | ERBB3 | 1.13057459 |
| 43 | PINK1 | 1.09392145 |
| 44 | ERN1 | 1.07826888 |
| 45 | MAP2K3 | 1.04408669 |
| 46 | MAP2K4 | 1.00478121 |
| 47 | TRPM7 | 0.98997454 |
| 48 | PTK2B | 0.98826618 |
| 49 | PAK3 | 0.97912928 |
| 50 | EPHA2 | 0.95289473 |
| 51 | LIMK1 | 0.95137082 |
| 52 | MAPKAPK3 | 0.93244919 |
| 53 | NEK6 | 0.92985614 |
| 54 | CASK | 0.92709897 |
| 55 | MAP3K9 | 0.91382249 |
| 56 | TAOK2 | 0.91141705 |
| 57 | PDGFRB | 0.90223696 |
| 58 | MAP3K5 | 0.90039507 |
| 59 | STK3 | 0.87810227 |
| 60 | MINK1 | 0.83401067 |
| 61 | MAP3K13 | 0.81328594 |
| 62 | MST1R | 0.79917682 |
| 63 | PIM2 | 0.79166436 |
| 64 | ROCK2 | 0.79069698 |
| 65 | NEK1 | 0.79003661 |
| 66 | EIF2AK3 | 0.78160037 |
| 67 | PLK2 | 0.75344937 |
| 68 | KSR1 | 0.75002873 |
| 69 | PTK2 | 0.74836007 |
| 70 | CDC42BPA | 0.74066157 |
| 71 | PDGFRA | 0.71464803 |
| 72 | MAPK7 | 0.70220322 |
| 73 | MET | 0.69232726 |
| 74 | MST4 | 0.68278982 |
| 75 | ILK | 0.67226255 |
| 76 | BCKDK | 0.66761527 |
| 77 | GRK7 | 0.66053957 |
| 78 | CDK18 | 0.65867638 |
| 79 | PIK3CG | 0.65165628 |
| 80 | PRKD1 | 0.64261699 |
| 81 | MAP2K1 | 0.64216343 |
| 82 | MAP3K4 | 0.60086873 |
| 83 | PTK6 | 0.59155547 |
| 84 | MOS | 0.59086032 |
| 85 | ERBB4 | 0.58702080 |
| 86 | EPHA4 | 0.58554642 |
| 87 | RET | 0.57274877 |
| 88 | JAK1 | 0.57241897 |
| 89 | PAK6 | 0.55337873 |
| 90 | BCR | 0.54822830 |
| 91 | MAP3K2 | 0.54612208 |
| 92 | MAP3K14 | 0.54029611 |
| 93 | WNK3 | 0.52323149 |
| 94 | STK38 | 0.50154594 |
| 95 | KIT | 0.49581988 |
| 96 | MAP3K7 | 0.49380488 |
| 97 | CAMK2G | 0.47847612 |
| 98 | TBK1 | 0.47775196 |
| 99 | SIK1 | 0.47624255 |
| 100 | MUSK | 0.46595782 |
| 101 | STK39 | 0.46238370 |
| 102 | PRKAA1 | 0.46021378 |
| 103 | CAMK4 | 0.45637225 |
| 104 | * GSK3A | 0.45570973 |
| 105 | TGFBR1 | 0.45220301 |
| 106 | CAMK2A | 0.44715277 |
| 107 | MAP3K1 | 0.44200032 |
| 108 | PAK2 | 0.43933224 |
| 109 | NEK9 | 0.43831421 |
| 110 | PRKCE | 0.43277513 |
| 111 | ADRBK1 | 0.43226371 |
| 112 | MARK1 | 0.42823331 |
| 113 | KSR2 | 0.42229687 |
| 114 | LRRK2 | 0.42052115 |
| 115 | DAPK3 | 0.41896298 |
| 116 | FGFR1 | 0.41741586 |
| 117 | GRK5 | 0.40885971 |
| 118 | CAMK2B | 0.40292276 |
| 119 | MAPKAPK2 | 0.40288692 |
| 120 | MAP3K6 | 0.40112553 |
| 121 | TYRO3 | 0.39510570 |
| 122 | PRKCG | 0.39469825 |
| 123 | PRKACG | 0.39172121 |
| 124 | TESK1 | 0.38365563 |
| 125 | PKN1 | 0.38327094 |
| 126 | FGFR4 | 0.38146260 |
| 127 | CAMK2D | 0.36678312 |
| 128 | NTRK1 | 0.36057321 |
| 129 | KDR | 0.34539440 |
| 130 | CDK15 | 0.34264020 |
| 131 | FGFR2 | 0.34148105 |
| 132 | NTRK3 | 0.32665998 |
| 133 | INSR | 0.32095554 |
| 134 | PDPK1 | 0.28265312 |
| 135 | CDK14 | 0.27055323 |
| 136 | PRKD2 | 0.26845904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.25535745 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.69002656 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.65590575 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.63720058 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48514341 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.45531977 |
| 7 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.32943505 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26945032 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 2.26825786 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.25356566 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.11294655 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.90022471 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.83551298 |
| 14 | Focal adhesion_Homo sapiens_hsa04510 | 1.80889697 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.71981707 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.65410563 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64589490 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40884275 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.37491154 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33313176 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.33249539 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33083213 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28181462 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26627171 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23824674 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22234495 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.21951537 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21299431 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19762152 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15757654 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13073421 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.12944584 |
| 33 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.12845047 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09315586 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08719653 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.08461892 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07254987 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07083231 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05411593 |
| 40 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.04755938 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.03703507 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03194897 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01773346 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.01357615 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.01183207 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98064857 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96364643 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94451603 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93655041 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93213703 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92482658 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91845734 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90601368 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.89298621 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87862613 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87662910 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87474543 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86964980 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85006983 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.84898721 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.83685968 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83528297 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81948188 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81685894 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80922755 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80411907 |
| 67 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78767625 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77822239 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77728331 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76739270 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75533783 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75504912 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74921861 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74086543 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72285493 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71417702 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71002617 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70881178 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69960462 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69054084 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68939973 |
| 82 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.68522042 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67721883 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.67261205 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65979656 |
| 86 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65938973 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.64813266 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63870818 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63836996 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63108682 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61768958 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61493075 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60865551 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60459645 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.60227674 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59836025 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58185696 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57572710 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57348355 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57109055 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.56769369 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56582448 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56266624 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55788291 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55571556 |
| 106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54968221 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54937316 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54580725 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54398035 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54263163 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54232521 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53773609 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53229791 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.52263191 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51282644 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49559158 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48869048 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48723593 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48675799 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48258319 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47957302 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.47107114 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47104134 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47077864 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46957005 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46514283 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46349843 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45875999 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45484437 |
| 130 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45418721 |
| 131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45267914 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44980489 |
| 133 | Shigellosis_Homo sapiens_hsa05131 | 0.44974660 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44838127 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43598597 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42965406 |
| 137 | Axon guidance_Homo sapiens_hsa04360 | 0.42244609 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42149452 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41863579 |
| 140 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41543804 |
| 141 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41181380 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41142551 |
| 143 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40362509 |
| 144 | Phagosome_Homo sapiens_hsa04145 | 0.40163265 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39497270 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37802112 |
| 147 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37610732 |
| 148 | Salivary secretion_Homo sapiens_hsa04970 | 0.37557067 |

